Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
0.584
-0.016 (-2.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.565
-0.019 (-3.27%)
After-hours: Apr 28, 2026, 6:25 PM EDT
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 31 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
31
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$42,290
Profits / Employee
-$267,968
Market Cap
2.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Adial Pharmaceuticals | 5 |
| CNS Pharmaceuticals | 5 |
| Oragenics | 3 |
SCNI News
- 4 days ago - Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today - Benzinga
- 4 days ago - Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing - PRNewsWire
- 22 days ago - Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities - PRNewsWire
- 27 days ago - Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration - PRNewsWire
- 5 weeks ago - Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026 - PRNewsWire
- 6 weeks ago - Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price - PRNewsWire
- 2 months ago - Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept - PRNewsWire
- 2 months ago - Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform - PRNewsWire